Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AngioGenex Inc (AGGX)
OTHER OTC:AGGX
AngioGenex (AGGX) Stock Price & Analysis
0 Followers
AGGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.00 - $0.40
Previous Close$0.2
Volume0.00
Average Volume (3M)N/A
Market Cap
$6.08K
Enterprise Value$61.28K
Total Cash (Recent Filing)$96.91K
Total Debt (Recent Filing)$152.12K
Price to Earnings (P/E)N/A
Beta0.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,386,667
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.75
R-Squared0.09
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AGGX FAQ
What was AngioGenex Inc’s price range in the past 12 months?
AngioGenex Inc lowest stock price was $0.00 and its highest was $0.40 in the past 12 months.
What is AngioGenex Inc’s market cap?
Currently, no data Available
When is AngioGenex Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AngioGenex Inc’s earnings last quarter?
Currently, no data Available
Is AngioGenex Inc overvalued?
According to Wall Street analysts AngioGenex Inc’s price is currently Overvalued.
Does AngioGenex Inc pay dividends?
AngioGenex Inc does not currently pay dividends.
What is AngioGenex Inc’s EPS estimate?
AngioGenex Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AngioGenex Inc have?
Currently, no data Available
What happened to AngioGenex Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AngioGenex Inc?
Currently, no hedge funds are holding shares in AGGX
---
Company Description
AngioGenex Inc
AngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra on March 31, 1999 and is headquartered in New York, NY.
---
Technical Analysis
---